
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
ZHX2 CRISPR/Cas9 KO Plasmid (m) | sc-436490 | 20 µg | $397.00 |
Zhx2 encodes the zinc fingers and homeoboxes protein 2 (ZHX2), a nuclear transcription factor that can act as a context-dependent regulator of gene expression through DNA binding and interactions with other transcriptional repressors. In mouse tissues, ZHX2 has been implicated in hepatocyte differentiation and maturation programs and in the control of liver-enriched metabolic gene networks, including pathways linked to lipid handling and xenobiotic processing. Altered ZHX2 activity has been associated with dysregulated transcriptional programs relevant to inflammation and tumor biology, making it a useful node for studying transcriptional control of tissue homeostasis. These properties support investigation of ZHX2-dependent chromatin and transcriptional mechanisms in development and disease-relevant cellular states.
ZHX2 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Zhx2 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Zhx2 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Zhx2 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish ZHX2 protein expression.
This CRISPR knockout system enables efficient generation of Zhx2-deficient cell models for investigation of ZHX2 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.